WAVE Life Sciences Ltd (WVE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

WAVE Life Sciences Ltd (WVE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH2305299D
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

WAVE Life Sciences Ltd (WAVE), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi, among others. It utilizes its proprietary synthetic chemistry platform to design, develop and commercialize nucleic acid therapeutics. The company's stereopure nucleic acid therapeutics are developed to affect the production of disease associated proteins and target rare genetic diseases. It controls the orientation of the chemical linkages. WAVE is headquartered in Cambridge, Massachusetts, the US.

WAVE Life Sciences Ltd (WVE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

WaVE Life Sciences Raises USD66 Million in Series B Financing Round 11

WaVe Life Sciences Raises USD18 Million in Series A Financing 12

Partnerships 13

nLife Therapeutics Enters into Research Agreement with WAVE Life Sciences 13

Wave Life Sciences Enters into Research Agreement with University of Dundee 13

Wave Life Sciences Enters into Licensing Agreement with Max Planck Innovation 14

Wave Life Sciences Enters into Research Agreement with Children's Hospital of Philadelphia 16

Wave Life Sciences Enters into Research Agreement with University of Oxford 17

Licensing Agreements 18

Pfizer Enters into Licensing Agreement with WAVE Life Sciences 18

Equity Offering 19

WAVE Life Sciences Prices Public Offering of Shares for USD100 Million 19

Wave Life Sciences Completes IPO For USD111.9 Million 20

WAVE Life Sciences Ltd-Key Competitors 23

Key Employees 24

Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Financial Announcements 26

May 10, 2017: WAVE Life Sciences Reports First Quarter 2017 Financial Results and Provides Business Update 26

Mar 16, 2017: WAVE Life Sciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Business Update 28

Nov 09, 2016: WAVE Life Sciences Reports Third Quarter 2016 Financial Results and Provides Business Update 30

Aug 15, 2016: WAVE Life Sciences Reports Second Quarter 2016 Financial Results and Provides Business Update 32

May 16, 2016: WAVE Life Sciences Reports First Quarter 2016 Financial Results and Provides Business Update 34

Mar 30, 2016: WAVE Life Sciences Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update 35

Corporate Communications 36

Nov 10, 2016: WAVE Life Sciences Appoints Christian Henry to its Board of Directors 36

Aug 17, 2016: WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer 37

Product News 38

01/06/2017: WAVE Life Sciences Provides Update on Duchenne Muscular Dystrophy Program WVE-210201 38

Other Significant Developments 39

May 09, 2016: WAVE Life Sciences to Advance Next-Generation Nucleic Acid Therapies to Address Unmet Need in Duchenne Muscular Dystrophy 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

List of Tables

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

WAVE Life Sciences Ltd, Deals By Therapy Area, 2011 to YTD 2017 9

WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

WaVE Life Sciences Raises USD66 Million in Series B Financing Round 11

WaVe Life Sciences Raises USD18 Million in Series A Financing 12

nLife Therapeutics Enters into Research Agreement with WAVE Life Sciences 13

Wave Life Sciences Enters into Research Agreement with University of Dundee 13

Wave Life Sciences Enters into Licensing Agreement with Max Planck Innovation 14

Wave Life Sciences Enters into Research Agreement with Children's Hospital of Philadelphia 16

Wave Life Sciences Enters into Research Agreement with University of Oxford 17

Pfizer Enters into Licensing Agreement with WAVE Life Sciences 18

WAVE Life Sciences Prices Public Offering of Shares for USD100 Million 19

Wave Life Sciences Completes IPO For USD111.9 Million 20

WAVE Life Sciences Ltd, Key Competitors 23

WAVE Life Sciences Ltd, Key Employees 24

WAVE Life Sciences Ltd, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

WAVE Life Sciences Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16235
Site License
USD 500 INR 32470
Corporate User License
USD 750 INR 48705

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com